Zobrazeno 1 - 10
of 357
pro vyhledávání: '"Daniel A. Arber"'
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms
Autor:
Amandeep Kaur, Alexandra E. Rojek, Emily Symes, Mariam T. Nawas, Anand A. Patel, Jay L. Patel, Payal Sojitra, Barina Aqil, Madina Sukhanova, Megan E. McNerney, Leo P. Wu, Aibek Akmatbekov, Jeremy Segal, Melissa Y. Tjota, Sandeep Gurbuxani, Jason X. Cheng, Su-Yeon Yeon, Harini V. Ravisankar, Carrie Fitzpatrick, Angela Lager, Michael W. Drazer, Caner Saygin, Pankhuri Wanjari, Panagiotis Katsonis, Olivier Lichtarge, Jane E. Churpek, Sharmila B. Ghosh, Ami B. Patel, Madhu P. Menon, Daniel A. Arber, Peng Wang, Girish Venkataraman
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Current therapies for high-grade TP53-mutated myeloid neoplasms (≥10% blasts) do not offer a meaningful survival benefit except allogeneic stem cell transplantation in the minority who achieve a complete response to first line therapy (CR1
Externí odkaz:
https://doaj.org/article/c0e050742d8c498c9f4fc3640be68aa0
Autor:
Faiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, Mrinal Patnaik, Aref Al-Kali, Michelle A. Elliott, Kebede H. Begna, Christopher C. Hook, William J. Hogan, Animesh Pardanani, Mark R. Litzow, Rhett P. Ketterling, Naseema Gangat, Daniel A. Arber, Attilio Orazi, Rong He, Kaaren Reichard, Ayalew Tefferi
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
The revised 4th edition of the World Health Organization (WHO4R) classification lists myelodysplastic syndromes with ring sideroblasts (MDS-RS) as a separate entity with single lineage (MDS-RS-SLD) or multilineage (MDS-RS-MLD) dysplasia. The more rec
Externí odkaz:
https://doaj.org/article/79912b1af5524ceab5f595d1fdf3afc5
Autor:
Olga K. Weinberg, Miguel D. Cantu, Jeffrey Gagan, Yazan F. Madanat, Daniel A. Arber, Robert P. Hasserjian
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 760-764 (2023)
Abstract A group of gene mutations has been identified to be strongly associated with secondary acute myeloid leukemias (AML) arising from prior myeloid neoplasms. The International Consensus Classification (ICC) and proposed 5th edition of the World
Externí odkaz:
https://doaj.org/article/04fbfac216474c0c84b3e58d4c915b53
Autor:
C. Cameron Yin, Wayne Tam, Serena M. Walker, Amandeep Kaur, Madhu M. Ouseph, Wei Xie, Olga K.Weinberg, Peng Li, Zhuang Zuo, Mark J. Routbort, Simon Chen, L. Jeffrey Medeiros, Tracy I George, Attilio Orazi, Daniel A. Arber, Adam Bagg, Robert P. Hasserjian, Sa A. Wang
Publikováno v:
Haematologica, Vol 109, Iss 6 (2023)
STAT5B has been reported as a recurrent mutation in myeloid neoplasms with eosinophilia, but its overall frequency and importance across a spectrum of myeloid neoplasms are largely unknown. We conducted a multicenter study on a series of 82 myeloid n
Externí odkaz:
https://doaj.org/article/d278b8f93dc24bc5a9ea8b492101f78d
Autor:
Peng Wang, Jeremy Segal, Michael W. Drazer, Girish Venkataraman, Daniel A. Arber, Sandeep Gurbuxani
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 962-965 (2022)
Externí odkaz:
https://doaj.org/article/7afa32af25924f69b70d28bb7d82c861
Publikováno v:
Human Pathology Reports, Vol 29, Iss , Pp 300663- (2022)
Follicular dendritic cell sarcomas (FDCS) are rare tumors derived from non-migrating antigen-presenting cells. They are distinguished from other histiocytic and dendritic cells by their immunophenotype, which supports a mesenchymal, non-myeloid stem
Externí odkaz:
https://doaj.org/article/3dbb358f9d084b4ab370a33c67251728
Autor:
Justin T. Kelley, Anna B. Owczarczyk, David O. Ferguson, Winston Y. Lee, Daniel A. Arber, Laura W. Lamps
Publikováno v:
Human Pathology Reports, Vol 28, Iss , Pp 300654- (2022)
Post-transplant lymphoproliferative disorders (PTLDs) are a group of hematopoietic proliferations classified into four categories depending on their morphology and resemblance to established lymphomas, including non-destructive, polymorphic (P-PTLD),
Externí odkaz:
https://doaj.org/article/9465706858904303b711871bc251aed3
Autor:
Peter Valent, Attilio Orazi, Michael R. Savona, Mrinal M. Patnaik, Francesco Onida, Arjan A. van de Loosdrecht, Detlef Haase, Torsten Haferlach, Chiara Elena, Lisa Pleyer, Wolfgang Kern, Tea Pemovska, Gregory I. Vladimer, Julie Schanz, Alexandra Keller, Michael Lübbert, Thomas Lion, Karl Sotlar, Andreas Reiter, Theo De Witte, Michael Pfeilstöcker, Klaus Geissler, Eric Padron, Michael Deininger, Alberto Orfao, Hans-Peter Horny, Peter L. Greenberg, Daniel A. Arber, Luca Malcovati, John M. Bennett
Publikováno v:
Haematologica, Vol 104, Iss 10 (2019)
Chronic myelomonocytic leukemia (CMML) is a myeloid neoplasm characterized by dysplasia, abnormal production and accumulation of monocytic cells and an elevated risk of transforming into acute leukemia. Over the past two decades, our knowledge about
Externí odkaz:
https://doaj.org/article/036e94854de14eff8e12ed73d92b78b7
Autor:
Sa A. Wang, Robert P. Hasserjian, Wayne Tam, Albert G. Tsai, Julia T. Geyer, Tracy I. George, Kathryn Foucar, Heesun J. Rogers, Eric D. Hsi, Bryan A. Rea, Adam Bagg, Carlos E. Bueso-Ramos, Daniel A. Arber, Srdan Verstovsek, Attilio Orazi
Publikováno v:
Haematologica, Vol 102, Iss 8 (2017)
Chronic eosinophilic leukemia, not otherwise specified can be difficult to distinguish from idiopathic hypereosinophilic syndrome according to the current World Health Organization guideline. To examine whether the morphological features of bone marr
Externí odkaz:
https://doaj.org/article/dd5f759331274b46a1c2cbb58b19cf31
Publikováno v:
Haematologica, Vol 99, Iss 7 (2014)
Externí odkaz:
https://doaj.org/article/c9e4c6e43e1e49e0bc42320fdab58720